Literature DB >> 28589322

Comparison of systemic lupus erythematosus (SLE) patients managed early after diagnosis in specialty versus community care clinics.

Roaa Aljohani1,2, Dafna D Gladman1, Jiandong Su1, Murray B Urowitz3.   

Abstract

To compare management and outcomes of SLE patients treated in community clinics (Cc) with those treated in specialty clinic (Sc) within 10 years after SLE diagnosis. A single-center, matched cohort study design was used. We identified 54 SLE patients who were referred to a Sc from Cc within 5 years of SLE diagnosis, and 101 inception SLE patients who followed in a Sc. Patients in Cc were matched 1:2 based on gender, decade of SLE diagnosis, and age at diagnosis within 3 years with Sc patients. Disease characteristics, damage accumulation, death, cardiovascular (CVS) risk factors, and events were compared at 5 and 10 years of disease. Regression analyses taking into account the paired data were conducted. At 5 years of disease, patients referred from Cc had less cumulative ACR criteria, but more active disease. They were on higher doses of glucocorticoids (GCS) but less antimalarial treatment. At 10 years of disease and follow-up entirely in Sc, Sc patients had less disease activity. They had lower cumulative GCS doses. They had less hypertension and osteoporosis but more hypercholesterolemia than Cc patients. No statistically significant difference in damage accrual, CVS events, and death were detected. Regression analysis confirmed an association between being inception Sc patients and less active disease at 10 years. Lupus patients should be under the care of a lupus specialist early in their disease course for better control of their disease activity and to minimize use of GCS.

Entities:  

Keywords:  Community care; Glucocorticosteroids; Outcomes; Specialty care

Mesh:

Substances:

Year:  2017        PMID: 28589322     DOI: 10.1007/s10067-017-3713-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  23 in total

Review 1.  Glucocorticoid use and abuse in SLE.

Authors:  Guillermo Ruiz-Irastorza; Alvaro Danza; Munther Khamashta
Journal:  Rheumatology (Oxford)       Date:  2012-01-23       Impact factor: 7.580

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

3.  Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual.

Authors:  Barri J Fessler; Graciela S Alarcón; Gerald McGwin; Jeffrey Roseman; Holly M Bastian; Alan W Friedman; Bruce A Baethge; Luis Vilá; John D Reveille
Journal:  Arthritis Rheum       Date:  2005-05

Review 4.  Atherosclerosis and systemic lupus erythematosus.

Authors:  M Urowitz; D Gladman; I Bruce
Journal:  Curr Rheumatol Rep       Date:  2000-02       Impact factor: 4.592

5.  Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events.

Authors:  K T Ho; C W Ahn; G S Alarcón; B A Baethge; F K Tan; J Roseman; H M Bastian; B J Fessler; G McGwin; L M Vilá; J Calvo-Alén; J D Reveille
Journal:  Rheumatology (Oxford)       Date:  2005-07-19       Impact factor: 7.580

6.  The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs.

Authors:  P Rahman; D D Gladman; M B Urowitz; K Yuen; D Hallett; I N Bruce
Journal:  J Rheumatol       Date:  1999-02       Impact factor: 4.666

7.  Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the National Database of the German Collaborative Arthritis Centres.

Authors:  A Zink; R Fischer-Betz; K Thiele; J Listing; D Huscher; E Gromnica-Ihle; C Specker; M Schneider
Journal:  Lupus       Date:  2004       Impact factor: 2.911

8.  Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus.

Authors:  Murray B Urowitz; Dafna D Gladman; Brian D M Tom; Dominique Ibañez; Vernon T Farewell
Journal:  J Rheumatol       Date:  2008-09-15       Impact factor: 4.666

Review 9.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

Authors:  D Gladman; E Ginzler; C Goldsmith; P Fortin; M Liang; M Urowitz; P Bacon; S Bombardieri; J Hanly; E Hay; D Isenberg; J Jones; K Kalunian; P Maddison; O Nived; M Petri; M Richter; J Sanchez-Guerrero; M Snaith; G Sturfelt; D Symmons; A Zoma
Journal:  Arthritis Rheum       Date:  1996-03

10.  Utilization of health services and prescription patterns among lupus patients followed by primary care physicians and rheumatologists in Puerto Rico.

Authors:  María J Molina; Angel M Mayor; Alejandro E Franco; Carlos A Morell; Miguel A López; Luis M Vilá
Journal:  Ethn Dis       Date:  2008       Impact factor: 1.847

View more
  4 in total

Review 1.  New therapeutic strategies in systemic lupus erythematosus management.

Authors:  Mariele Gatto; Margherita Zen; Luca Iaccarino; Andrea Doria
Journal:  Nat Rev Rheumatol       Date:  2019-01       Impact factor: 20.543

2.  Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies.

Authors:  Manuel Francisco Ugarte-Gil; Anselm Mak; Joanna Leong; Bhushan Dharmadhikari; Nien Yee Kow; Cristina Reátegui-Sokolova; Claudia Elera-Fitzcarrald; Cinthia Aranow; Laurent Arnaud; Anca D Askanase; Sang-Cheol Bae; Sasha Bernatsky; Ian N Bruce; Jill Buyon; Nathalie Costedoat-Chalumeau; Mary Ann Dooley; Paul R Fortin; Ellen M Ginzler; Dafna D Gladman; John Hanly; Murat Inanc; David Isenberg; Soren Jacobsen; Judith A James; Andreas Jönsen; Kenneth Kalunian; Diane L Kamen; Sung Sam Lim; Eric Morand; Marta Mosca; Christine Peschken; Bernardo A Pons-Estel; Anisur Rahman; Rosalind Ramsey-Goldman; John Reynolds; Juanita Romero-Diaz; Guillermo Ruiz-Irastorza; Jorge Sánchez-Guerrero; Elisabet Svenungsson; Murray Urowitz; Evelyne Vinet; Ronald F van Vollenhoven; Alexandre Voskuyl; Daniel J Wallace; Michelle A Petri; Susan Manzi; Ann Elaine Clarke; Mike Cheung; Vernon Farewell; Graciela S Alarcon
Journal:  Lupus Sci Med       Date:  2021-12

3.  From Symptoms to Diagnosis: An Observational Study of the Journey of SLE Patients in Saudi Arabia.

Authors:  Mishal F Karremah; Rola Y Hassan; Ammar Z Faloudah; Lujain K Alharbi; Albraa F Shodari; Ahmad A Rahbeeni; Nouf K Alharazi; Ahmad Z Binjabi; Mohamed M Cheikh; Hanadi Manasfi; Sultana Abdulaziz; Albadr Hamza Hussein; Ahmed Alhazmi; Hani Almoallim
Journal:  Open Access Rheumatol       Date:  2022-06-29

Review 4.  Systemic Lupus Erythematosus in Primary Care: An Update and Practical Messages for the General Practitioner.

Authors:  Irini Gergianaki; George Bertsias
Journal:  Front Med (Lausanne)       Date:  2018-05-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.